Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > Re: Justa Askin'
View:
Post by ISAloser247 on Feb 17, 2010 11:52am

Re: Justa Askin'




      It has been a week, not much on the board, but dem der pumpers.

     Anyone know yet ,Who owns the patents?  What is the burn rate?  When do the lights get turned off?

     And the questions that always are  answered,  Any cars in the parking lot?  Dr.Fo still onhigh on  his Hog?
Comment by bromley1877 on Feb 17, 2010 1:08pm
There have already been several posts on this but once again, the patents or at least most of them are technically “owned” by Palladin but that they have been licensed back to ISA in perpetuity so, outside of the loss of some potential tax writes offs, economically it is pretty much the same thing as ISA owning them.As for cash on hand and the burn rate, the year end financials will be out fairly ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities